| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7976 |
| Human Intestinal Absorption | HIA+ | 0.9914 |
| Caco-2 Permeability | Caco2+ | 0.7091 |
| P-glycoprotein Substrate | Non-substrate | 0.7610 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9374 |
| Non-inhibitor | 0.9364 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8348 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7925 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8183 |
| CYP450 2D6 Substrate | Non-substrate | 0.8675 |
| CYP450 3A4 Substrate | Non-substrate | 0.7586 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5458 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9032 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9496 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6219 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8989 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6132 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8508 |
| Non-inhibitor | 0.9295 |
| AMES Toxicity | Non AMES toxic | 0.7624 |
| Carcinogens | Non-carcinogens | 0.8456 |
| Fish Toxicity | Low FHMT | 0.7394 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8365 |
| Honey Bee Toxicity | High HBT | 0.7278 |
| Biodegradation | Ready biodegradable | 0.9097 |
| Acute Oral Toxicity | II | 0.6063 |
| Carcinogenicity (Three-class) | Non-required | 0.7656 |